Green tea polyphenols in drug discovery: a success or failure?

Bibliography

• Yang CS, Wang ZY. Tea and cancer. J National Cancer Inst 1993;85:1038-49
   PubMed Web of Science ®Google Scholar
• Maron DJ, Lu GP, Cai NS, Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med 2003;163:1448-53
   PubMed Web of Science ®Google Scholar
• Hamilton-Miller JM. Antimicrobial properties of tea (Camellia sinensis L.). Antimicrob Agents Chemother 1995;39:2375-7
   PubMed Web of Science ®Google Scholar
• Stolcov C, Saffari R, Houghton JM. Green tea inhibits Helicobacter growth in vivo and in vitro. Int J Antimicrob Agents 2009;33:473-8
   PubMed Web of Science ®Google Scholar
• Katiyar SK, Mukhtar H. Tea in chemoprevention of cancer: epidemiologic and experimental studies. Int J Oncol 1996;8:221-38
   PubMed Web of Science ®Google Scholar
• Shanafelt TD, Call TG, Zent CS, Phase I trial of daily oral polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia. J Clin Oncology 2009;27:3808-14
   PubMed Web of Science ®Google Scholar
• Waltner-Law ME, Wang XL, Law BK, Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 2002;277:34933-40
   PubMed Web of Science ®Google Scholar
• Anderson RA, Polansky MM. Tea enhances insulin activity. J Agric Food Chem 2002;50:7182-6
   PubMed Web of Science ®Google Scholar
• Baer DJ, Novotny JA, Harris GK, Oolong tea does not improve glucose metabolism in non-diabetic adults. Eur J Clin Nutrition 2011;65:87-93
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Yamazaki S, Kano K, Kinetic analysis and mechanistic aspects of autoxidation of catechins. Biochim Biophys Acta 2002;1569:35-44
   PubMed Web of Science ®Google Scholar
• Hong J, Lu H, Meng X, Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-) epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res 2002;62:7241-6
   PubMed Web of Science ®Google Scholar
• Sang S, Lee M-J, Hou Z, Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions. J Agric Food Chem 2005;53:9478-84
   PubMed Web of Science ®Google Scholar
• Hou Z, Sang S, You H, Mechanism of action of (-)-epigallocatechin-3-gallate: Auto-oxidation dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res 2005;65:8049-56
   PubMed Web of Science ®Google Scholar
• Chan KY, Zhang L, Zou Z. Intestinal efflux transport kinetics of green tea catechins in Caco-2 monolayer model. J Pharm Pharmacol 2007;59:395-400
   PubMed Web of Science ®Google Scholar
• Feng WY. Metabolism of green tea catechins: an overview. Curr Drug Met 2006;7:755-809
   PubMed Web of Science ®Google Scholar
• Lee MJ, Maliakal P, Chen L, Pharmocokinetics of tea catechins after ingestion ofgreen tea an (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variabilty. Cancer Epidemiol Biomarkers Prev 2002;11:1025-32
   PubMed Web of Science ®Google Scholar
• Lambert JD, Lee M-J, Lu H, Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J Nutr 2003;133:4172-7
   PubMed Web of Science ®Google Scholar
• Manach C, Williamson G, Morand C, Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005;81:230S-242S
   PubMed Web of Science ®Google Scholar
• Lee H, Bae JH, Lee S-R. Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils. J Neurosci Res 2004;77:892-900
   PubMed Web of Science ®Google Scholar
• Nakagawa K, Okuda S, Miyazawa T. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci Biotechnol Biochem 1997;61:1981-5
   PubMed Web of Science ®Google Scholar
• Unno T, Kondo K, Itakura H, Analysis of (-)-epigallocatechin gallate in human serum obtained after ingesting green tea. Biosci Biotechnol Biochem 1996;60:2066-8
   PubMed Web of Science ®Google Scholar
• Pietta P, Simonetti P, Gardana C, Relationship between rate and extent of catechin absorption and plasma antioxidant status. Biochem Mol Biol Int 1998;46:895-903
   PubMedGoogle Scholar
• Lee MJ, Wang Z-Y, Li H, Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev 1995;4:393-9
   PubMed Web of Science ®Google Scholar
• Chow H-HS, Cai Y, Alberts DS, Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev 2001;10:53-8
   PubMed Web of Science ®Google Scholar
• Chen D, Wang CY, Lambert JD, Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies. Biochem Pharmacol 2005;69:1523-31
   PubMed Web of Science ®Google Scholar
• Landis-Piwowar KR, Wan SB, Weigand RA, Methylation suppresses the proteasome-inhibitory function of green tea polyphenols. J Cell Phys 2007;213:252-60
   PubMed Web of Science ®Google Scholar
• Wu AH, Yu MC, Tseng CC, Green tea and risk of breast cancer in Asian Americans. Int J Cancer 2003;106:574-9
   PubMed Web of Science ®Google Scholar
• Liederer BM, Borchardt RT. Enzymes involved in the bioconversion of ester-based prodrugs. J Pharm Sci 2006;95:1177-95
   PubMed Web of Science ®Google Scholar
• Lambert JD, Sang S, Hong JJJ, Peracetylation as a means of enhancing in-vitro bioactvity and bioavailability of epigallocatechin-3-gallate. Drug Metab Dispos 2006;34:2111-16
   PubMed Web of Science ®Google Scholar
• Demeule M, Brossard M, Page M, Matrix metalloproteinase inhibition by green tea catechins. Biochim Biophys Acta 2000;1478:51-60
   PubMed Web of Science ®Google Scholar
• Nam S, Smith DM, Dou QP. Ester bond-containing tea polyphenols potently inhibit proteasome activity in-vitro and in-vivo. J Biol Chem 2001;276:13322-30
   PubMed Web of Science ®Google Scholar
• Navarro-Peran E, Cabezas-Herrera J, Hiner AN, Kinetics of the inhibition of bovine liver dihydrofolate reductase by tea catechins: origin of slow-binding inhibition and pH studies. Biochemistry 2005;44:7512-25
   PubMed Web of Science ®Google Scholar
• Abe T, Seki T, Umehara K, Green tea polyphenols: novel and potent inhibitors of squalene epoxidase. Biochem Biophys Res Commun 2000;268:767-71
   PubMed Web of Science ®Google Scholar
• Robertson IM, Li MX, Sykes BD. Solution structure of human cardiac troponin C in complex with green tea polyphenol, (-)-epigallocatechin 3-gallate. J Biol Chem 2009;284:23012-23
   PubMed Web of Science ®Google Scholar
• Miyata M, Sato T, Kugimiya M, The crystal structure of the green tea polyphenol (-)-epigallocatechin gallate-transthyretin complex reveals a novel binding site distinct from the thyroxine binding site. Biochemistry 2010;49:6104-14
   PubMed Web of Science ®Google Scholar
• Golden EB,. Lam PY, Kardosh A, et al. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 2009;113:5927-37
   PubMed Web of Science ®Google Scholar
• Stanley CA, Lieu YK, Hsu BY, Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 1998;338:1352-7
   PubMed Web of Science ®Google Scholar
• Hsu BY, Kelly A, Thornton PS, Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr 2001;138(3):383-9
   PubMed Web of Science ®Google Scholar
• Bahi-Buisson N, Roze E, Dionisi C, Neurological aspects of hyperinsulinism-hyperammonaemia syndrome. Dev Med Child Neurol 2008;50:945-9
   PubMed Web of Science ®Google Scholar
• Li C, Allen A, Kwagh K, Green tea polyphenols modulate insulin secretion by inhibiting glutamate dehydrogenase. J Biol Chem 2006;281:10214-21
   PubMed Web of Science ®Google Scholar
• Smith TJ, Stanley CA. Untangling the glutamate dehydrogenase allosteric nightmare. Trends Biol Chem 2008;33:557-64
   PubMed Web of Science ®Google Scholar
• Yang C, Sudderth J, Dang T, Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Cancer Res 2009;69:7986-93
   PubMed Web of Science ®Google Scholar
• Choo AY, Kim SG, Vander Heiden MG, Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply. Molecular Cell 2010;38:487-99
   PubMed Web of Science ®Google Scholar